ProPhase Labs, Inc. (NASDAQ:PRPH)

About the company

ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over-the-counter consumer consumer healthcare products and dietary supplements. Its products include TK supplement. The company was founded by Guy J. Quigley and Charles A. Phillips in July 1989 and is headquartered in Doylestown, PA.

Sector

Health Technology

Industry

Pharmaceuticals: Major

Employees

48

$9.00M

Total Revenue

48

Employees

$17.04M

Market Capitalization

-5.68

Price/Earning ratio

Stock price

Gross Margin (in %)

Total gross margin

$2M

Operating Margin (in %)

Total operating margin

$-3M

Net Margin (in %)

Total net margin

$-3M

Dividend Yield (in %)

Dividend per share

$0

Industry peers

Name Ticker Market capitalization (in USD Million) Revenues (in USD Million) Price/Book Price/Earning Net margin (in %)
Johnson & Johnson JNJ 382409.47 82729.00 6.14 22.29 20.75
Merck & Co., Inc. MRK 201995.52 48081.00 7.58 19.93 21.10
Pfizer Inc. PFE 191963.22 50660.00 2.91 12.15 31.17
Eli Lilly & Co. LLY 155261.34 23087.00 52.69 27.37 23.97
AbbVie, Inc. ABBV 147435.40 34057.00 -23.60 17.58 24.65
Bristol Myers Squibb Co. BMY 111646.60 31006.00 2.71 94.92 3.08
Repligen Corp. RGEN 6389.28 286.00 6.13 278.40 8.11
Reata Pharmaceuticals, Inc. RETA 4824.84 20.00 22.85 -15.52 -150.30
Nektar Therapeutics NKTR 4363.04 137.00 3.41 -9.50 -335.62
Biohaven Pharmaceutical Holding Co. Ltd. BHVN 4053.40 1.00 37.48 -6.20 None
Allakos, Inc. ALLK 3236.42 None 7.03 -34.60 None
Karuna Therapeutics, Inc. KRTX 2853.24 None 7.45 -70.35 None
ADC Therapeutics SA ADCT 2565.54 2.00 30.26 -22.00 None
OPKO Health, Inc. OPK 2332.47 891.00 1.66 -7.98 -32.92
Turning Point Therapeutics, Inc. TPTX 2259.72 None 6.80 -18.91 None
IGM Biosciences, Inc. IGMS 2237.27 None 9.86 -41.24 None
Apellis Pharmaceuticals, Inc. APLS 2175.36 None 9.61 -5.22 None
Ra Pharmaceuticals, Inc. RARX 2111.78 3.00 8.68 -20.78 -585.71
Springworks Therapeutics, Inc. SWTX 1639.59 None 5.33 -26.30 None
Zymeworks, Inc. ZYME 1622.04 26.00 3.37 -9.56 -629.37
Principia Biopharma, Inc. PRNB 1578.64 30.00 5.62 -22.46 -242.01
Y-mAbs Therapeutics, Inc. YMAB 1544.38 None 9.46 -16.76 None
Akcea Therapeutics, Inc. AKCA 1341.51 341.00 2.75 -47.69 -8.59
Tricida, Inc. TCDA 1310.26 None 6.74 -6.20 None
Kiniksa Pharmaceuticals Ltd. KNSA 1305.15 None 6.76 -10.79 None
Arcutis Biotherapeutics, Inc. ARQT 1184.00 None 5.05 -18.93 None
Odonate Therapeutics, Inc. ODT 1121.14 None 9.18 -9.96 None
Akero Therapeutics, Inc. AKRO 1074.74 None 8.97 -21.18 None
Athenex, Inc. ATNX 1064.70 123.00 6.53 -9.89 -87.86
Phibro Animal Health Corp. PAHC 1060.26 818.00 5.35 28.73 4.49
Constellation Pharmaceuticals, Inc. CNST 966.40 None 4.55 -10.41 None
G1 Therapeutics, Inc. GTHX 818.52 1.00 3.54 -6.24 None
Gossamer Bio, Inc. GOSS 809.47 None 3.28 -4.07 None
Phathom Pharmaceuticals, Inc. PHAT 794.00 None 4.40 -2.92 None
Quanterix Corp. QTRX 732.51 60.00 6.46 -16.75 -71.52
Krystal Biotech, Inc. KRYS 731.00 None 4.26 -35.25 None
Applied Therapeutics, Inc. APLT 711.70 14.00 4.60 -14.44 -19.41
Aprea Therapeutics, Inc. APRE 689.64 None 6.10 -20.40 None
Oric Pharmaceuticals, Inc. ORIC 687.96 None -7.47 -22.75 None
Provention Bio, Inc. PRVB 669.94 None 10.60 -15.13 None
Provention Bio, Inc. PRVB 651.88 None 10.31 -14.72 None
Arcturus Therapeutics Holdings, Inc. ARCT 645.58 19.00 59.83 -23.21 -151.34
Amneal Pharmaceuticals, Inc. AMRX 617.87 1679.00 4.25 -2.84 -11.85
Keros Therapeutics, Inc. KROS 606.78 8.00 -27.41 -28.57 -285.35
Oyster Point Pharma, Inc. OYST 548.10 None 5.51 -9.53 None
Mirum Pharmaceuticals, Inc. MIRM 486.50 None 3.16 -7.18 None
Fulcrum Therapeutics, Inc. FULC 476.10 1.00 8.02 -6.90 None
Satsuma Pharmaceuticals, Inc. STSA 476.00 None 4.68 -13.08 None
SIGA Technologies, Inc. SIGA 475.60 19.00 5.32 -24.17 -94.00
89bio, Inc. ETNB 462.70 None 5.71 -7.17 None
Biospecifics Technologies Corp. BSTC 462.28 40.00 3.75 19.77 61.80
Imara, Inc. IMRA 438.60 None 4.24 -12.46 None
Crinetics Pharmaceuticals, Inc. CRNX 414.72 1.00 5.24 -7.11 -447.78
DURECT Corp. DRRX 405.48 28.00 31.14 -16.77 -82.94
Relmada Therapeutics, Inc. RLMD 394.02 0.00 5.88 -32.92 -877.66
Kala Pharmaceuticals, Inc. KALA 383.04 6.00 4.19 -4.17 None
TCR2 Therapeutics, Inc. TCRR 368.64 None 2.52 -36.57 None
Ocular Therapeutix, Inc. OCUL 367.20 6.00 -45.00 -4.01 None
Ovid Therapeutics, Inc. OVID 344.25 None 8.14 -5.28 None
Osmotica Pharmaceuticals Plc OSMT 343.44 232.00 2.61 -1.25 -115.44
Aeglea Biotherapeutics, Inc. AGLE 303.27 4.00 9.57 -3.78 -523.27
Urovant Sciences Ltd. UROV 295.80 None -5.24 -2.05 None
IDEAYA Biosciences, Inc. IDYA 270.40 None 4.11 -6.20 None
Spero Therapeutics, Inc. SPRO 268.28 12.00 3.53 -3.30 -656.72
AMAG Pharmaceuticals, Inc. AMAG 268.26 321.00 1.02 -0.72 -115.05
HOOKIPA Pharma, Inc. HOOK 267.80 13.00 2.42 -5.92 -333.02
Verrica Pharmaceuticals, Inc. VRCA 257.50 None 4.70 -8.44 None
Lannett Co., Inc. LCI 252.32 542.00 0.86 -8.30 -5.77
Gritstone Oncology, Inc. GRTS 226.44 4.00 2.03 -2.17 None
Kaleido Biosciences, Inc. KLDO 221.10 None 7.84 -3.02 None
KalVista Pharmaceuticals, Inc. KALV 211.68 12.00 2.34 -6.53 -263.38
Veru, Inc. VERU 207.35 39.00 6.93 -21.27 -25.53
Protara Therapeutics, Inc. TARA 191.34 None 2.88 -12.41 None
Galera Therapeutics, Inc. GRTX 187.25 None 3.50 -2.85 None
Sutro Biopharma, Inc. STRO 184.92 41.00 3.51 -3.03 -148.06
LogicBio Therapeutics, Inc. LOGC 179.63 1.00 5.42 -4.22 None
Liquidia Technologies, Inc. LQDA 166.10 8.00 13.02 -3.37 -602.17
Cyclerion Therapeutics, Inc. CYCN 156.60 6.00 1.97 -1.51 None
Avenue Therapeutics, Inc. ATXI 155.20 532.00 28.53 -10.66 26.69
Tyme Technologies, Inc. TYME 144.90 None 8.40 -6.63 None
Lyra Therapeutics, Inc. LYRA 144.84 1.00 -1.23 -8.68 -491.16
Evelo Biosciences, Inc. EVLO 144.00 None 5.29 -1.64 None
scPharmaceuticals, Inc. SCPH 138.32 119.00 3.53 -4.41 -27.05
PhaseBio Pharmaceuticals, Inc. PHAS 134.85 2.00 2.50 -2.82 None
Harrow Health, Inc. HROW 133.38 51.00 8.55 -5.40 -47.54
Aquestive Therapeutics, Inc. AQST 128.24 49.00 -7.39 -1.82 -139.64
Mustang Bio, Inc. MBIO 128.00 None 2.99 -2.60 None
TFF Pharmaceuticals, Inc. TFFP 118.18 None 4.57 -3.05 None
Immunic, Inc. IMUX 117.40 None 3.45 -53.36 None
NeuBase Therapeutics, Inc. NBSE 117.04 None 49.18 -2.62 None
Ayala Pharmaceuticals, Inc. AYLA 115.41 3.00 -2.72 -5.59 -679.19
Evolus, Inc. EOLS 100.50 45.00 1.80 -0.99 -217.51
Eton Pharmaceuticals, Inc. ETON 99.90 1.00 10.88 -5.00 None
Trevi Therapeutics, Inc. TRVI 98.82 None 2.10 -3.37 None
Milestone Pharmaceuticals, Inc. MIST 95.00 None 0.94 -1.53 None
Corvus Pharmaceuticals, Inc. CRVS 79.46 None 1.27 -1.68 None
EyePoint Pharmaceuticals, Inc. EYPT 78.49 26.00 5.54 -1.60 -196.30
Clearside Biomedical, Inc. CLSD 77.49 6.00 9.95 -4.40 -293.61
Checkpoint Therapeutics, Inc. CKPT 76.80 2.00 6.62 -3.31 -949.53
Xeris Pharmaceuticals, Inc. XERS 74.48 4.00 3.69 -0.57 None
Navidea Biopharmaceuticals, Inc. NAVB 67.15 1.00 -49.38 -6.08 -65.13
Baudax Bio, Inc. BXRX 65.70 None -1.79 -0.94 None
BiomX, Inc. PHGE 60.06 None 1.58 -1.40 None
Genprex, Inc. GNPX 59.85 None 5.08 -4.38 None
Assertio Therapeutics, Inc. ASRT 57.60 192.00 1.00 -0.35 -83.99
Aridis Pharmaceuticals, Inc. ARDS 55.44 1.00 -22.81 -1.90 -851.00
Aerpio Pharmaceuticals, Inc. ARPO 53.71 20.00 1.62 -2.85 -51.58
Menlo Therapeutics, Inc. MNLO 49.30 2.00 4.15 -0.53 -483.51
Annovis Bio, Inc. ANVS 47.46 None 4.35 -37.67 None
Eyenovia, Inc. EYEN 45.44 None 4.58 -2.22 None
Edesa Biotech, Inc. EDSA 44.82 0.00 6.38 -0.47 -395.23
Moleculin Biotech, Inc. MBRX 40.94 None 3.56 -4.45 None
Citius Pharmaceuticals, Inc. CTXR 36.45 None 2.70 -2.11 None
Akari Therapeutics Plc AKTX 36.18 None -33.50 -2.01 None
Mannatech, Inc. MTEX 33.70 156.00 1.42 7.59 3.45
Oncternal Therapeutics, Inc. ONCT 33.67 3.00 4.32 -1.34 -225.89
Allena Pharmaceuticals, Inc. ALNA 33.58 None 4.42 -0.77 None
AgeX Therapeutics, Inc. AGE 33.44 2.00 -44.00 -2.75 -658.11
Acer Therapeutics, Inc. ACER 32.20 3.00 2.35 -1.23 -274.69
CNS Pharmaceuticals, Inc. CNSP 31.20 None 5.42 -5.74 None
Aileron Therapeutics, Inc. ALRN 30.80 None 4.23 -1.16 None
Adamis Pharmaceuticals Corp. ADMP 30.16 22.00 1.16 -1.02 -140.33
Hoth Therapeutics, Inc. HOTH 25.40 None 7.06 -2.82 None
Millendo Therapeutics, Inc. MLND 25.27 0.00 0.60 -0.54 None
Spring Bank Pharmaceuticals, Inc. SBPH 24.64 0.00 0.93 -0.94 None
Akorn, Inc. AKRX 22.68 721.00 -1.20 -0.06 -55.64
Daré Bioscience, Inc. DARE 18.81 1.00 8.25 -1.13 None
ProPhase Labs, Inc. PRPH 17.04 9.00 1.54 -5.68 -31.15
Teligent, Inc. TLGT 14.40 60.00 -0.49 -0.36 -71.80
Teligent, Inc. TLGT 14.40 60.00 -0.49 -0.36 -71.80
Novan, Inc. NOVN 14.33 5.00 -3.29 -0.45 -602.34
Adial Pharmaceuticals, Inc. ADIL 13.80 None 3.37 -1.82 None
PDS Biotechnology Corp. PDSB 12.88 None 1.43 -0.50 None
Titan Pharmaceuticals, Inc. TTNP 12.07 4.00 5.03 -0.67 -437.91
Novus Therapeutics, Inc. NVUS 7.44 None 0.64 -0.35 None
Brickell Biotech, Inc. BBI 4.68 5.00 1.53 -0.06 -432.19
BioStar Pharmaceuticals, Inc. BSPM 0.21 0.00 0.01 0.10 294.01

Latest insider transactions

Date Role Name Transaction Quantity Quantity Owned After

ProPhase Labs Inc.

23d ago, source: MarketWatch

01/30/2018 N/A SC 13G/A Institutional Ownership * 10/02/2017 N/A SC 13G Institutional Ownership 02/05/2015 N/A SC 13G/A Institutional Ownership * 09/11/2014 N/A SC 13G/A Institutional Ownership ...

PRPH ProPhase Labs, Inc. Common Stock (DE)

26d ago, source: Nasdaq

Institutional Holdings information is filed by major institutions on form 13-F with the Securities and Exchange Commission. Major institutions are defined as firms or individuals that exercise ...

Hedge Funds Warming Up To Seelos Therapeutics, Inc. (SEEL)

1mon ago, source: YAHOO!

These stocks are Dawson Geophysical Company (NASDAQ:DWSN), Cinedigm Corp (NASDAQ:CIDM), ProPhase Labs Inc (NASDAQ:PRPH), and Reed's, Inc. (NASDAQ:REED). This group of stocks' market valuations ...

Oral Spray Market 2020 Potential Growth, Share, Demand and Analysis of Key Players- Research Forecasts To 2025

1mon ago, source: MarketWatch

The MarketWatch News Department was not involved in the creation of this content. Jun 02, 2020 (The Expresswire) -- The research report of “Oral Spray Market” study report covers all main ...

ProPhase Labs Inc

3mon ago, source: Reuters

* BOARD OF DIRECTORS HAS DECLARED A SPECIAL CASH DIVIDEND IN AMOUNT OF $1.00 PER SHARE ON ITS COMMON STOCK Source text for Eikon: Further company coverage: BRIEF-Prophase Labs Announces New ...

PRPH ProPhase Labs, Inc. Common Stock (DE)

15d ago, source: Nasdaq

Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary and as a result, these ...

ProPhase Labs PRICES

1y ago, source: Business Insider

Disclaimer | Commerce Policy | Made In NYC | Stock quotes by finanzen.net US Stock Markets ProPhase Labs Inc Stock Exchanges* ProPhase Labs Inc Historical Prices ProPhase Labs Inc From ProPhase ...



Portfolio items

Follow companies to create your optimal portfolio.
or
Refresh this page to see your newly added stocks.